Optometrists in Wauwatosa, WI Accepting Medicare
18 Optometrists found. Showing 1 - 18
 Mary Szcygiel, OD Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2500 N Mayfair Rd, Wauwatosa, WI 53226 Phone: 414-453-2866 Fax: 414-453-0730 |
 Myeyedr. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2505 N Mayfair Rd Ste 100, Wauwatosa, WI 53226 Phone: 414-453-7020 Fax: 414-453-9980 |
 Dr. Michael A Steck, O.D. Optometrist Medicare: Medicare Enrolled Practice Location: 2500 N Mayfair Rd, Wauwatosa, WI 53226 Phone: 414-453-2315 |
Maria Martha Steck, O.D. Optometrist - Corneal and Contact Management Medicare: Accepting Medicare Assignments Practice Location: 11530 W Burleigh St, Space 110, Wauwatosa, WI 53222 Phone: 414-453-2275 |
Dr. Megan E Lind, O.D. Optometrist Medicare: May Accept Medicare Assignments Practice Location: 6412 W North Ave, Wauwatosa, WI 53213 Phone: 414-774-2020 Fax: 414-774-0530 |
William H. Jeselun, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2500 N Mayfair Rd, Wauwatosa, WI 53226 Phone: 414-453-2866 Fax: 414-453-0730 |
Eye Care Vision Center Of Wauwatosa, Inc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 6412 W North Ave, Wauwatosa, WI 53213 Phone: 414-774-2020 |
Hansen Eyecare Llc Optometrist Medicare: Medicare Enrolled Practice Location: 7831 Eagle St, Wauwatosa, WI 53213 Phone: 253-341-5091 Fax: 630-206-2815 |
Dr. Cynthia G Johnson, O.D. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2500 N Mayfair Rd, Wauwatosa, WI 53226 Phone: 414-771-8999 |
Steck Eye Care Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2500 N Mayfair Rd, Wauwatosa, WI 53226 Phone: 414-453-2315 |
Dr. Mathew J. Schuller, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 3720 N 124th St, Suite F, Wauwatosa, WI 53222 Phone: 414-535-8134 Fax: 414-535-8135 |
Dr. John Thomas Meek, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2500 N Mayfair Rd, Wauwatosa, WI 53226 Phone: 414-453-2866 |
Dr. Brian J Jurgens, OD Optometrist Medicare: Medicare Enrolled Practice Location: 2300 N Mayfair Rd, #1155, Wauwatosa, WI 53226 Phone: 414-258-6880 Fax: 414-258-5686 |
Badger Vision Center, Llc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 2505 N Mayfair Rd, Ste 100, Wauwatosa, WI 53226 Phone: 414-453-7020 Fax: 414-453-9980 |
Dr. Gregory Thomas Pierangeli, OD Optometrist - Corneal and Contact Management Medicare: Accepting Medicare Assignments Practice Location: 2505 N Mayfair Rd Ste 100, Wauwatosa, WI 53226 Phone: 414-453-7020 Fax: 414-453-9980 |
Be Spectacled Optometrist Medicare: Medicare Enrolled Practice Location: 7511 Harwood Ave, Wauwatosa, WI 53213 Phone: 414-453-1300 Fax: 414-453-1330 |
Eye Care Vision Center Of Wauwatosa Optometrist Medicare: Medicare Enrolled Practice Location: 6412 W North Ave, Wauwatosa, WI 53213 Phone: 414-774-2020 |
Dr. Joel D. Baisden, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 2505 N Mayfair Rd, #100, Wauwatosa, WI 53226 Phone: 414-453-7020 Fax: 414-453-9980 |
News Archive
Once-a-day dosing clinical study of udenafil for erectile dysfunction completed
Dong-A Pharmaceutical Co., Ltd. and Dong-A PharmTech, Co. Ltd. announced today that it has completed a 240 patient once-a-day dosing clinical study of udenafil, its new long acting phosphodiesterase type 5 (PDE-5) inhibitor for erectile dysfunction (ED).
Applied Integrin Sciences' drug candidate eliminates ovarian cancer tumors in pre-clinical study
Applied Integrin Sciences, Inc. announced today that its first cancer therapeutic drug candidate eliminated all intraperitoneal ovarian cancer tumors in a pre-clinical study testing a novel treatment regimen.
Daiichi Sankyo completes patient enrollment in Phase III edoxaban study for AF
Daiichi Sankyo Company, Limited (TSE: 4568) announced today that it has successfully completed patient enrollment for its Phase III ENGAGE AF-TIMI 48 clinical study of edoxaban, a direct, specific, oral Factor Xa inhibitor that is being investigated in two different dosing regimens given once daily, to prevent the occurrence of strokes and systemic embolic events (SEE) in patients with atrial fibrillation (AF).
Enobia Pharma's clinical study of ENB-0040 for treating hypophosphatasia provides positive results
Enobia Pharma today announced positive data from a clinical study of ENB-0040, a bone targeted enzyme replacement therapy, under investigation for the treatment of hypophosphatasia (HPP). After six months of treatment with ENB-0040, four of five severely affected patients showed marked improvements in bone mineralization, correction of skeletal defects, better respiratory function, including weaning from assisted ventilation, and cognitive and motor development.
Entire genetic blueprints of more than 2,000 human and avian influenza viruses completed and made public
The Influenza Genome Sequencing Project, funded by the National Institute of Allergy and Infectious Diseases (NIAID), announced today that it has achieved a major milestone.
› Verified 7 days ago
Physical Therapists
Chiropractors
Occupational Therapists
Speech-Language Pathologists
Optometrists
Audiologists
Podiatrists